Literature DB >> 19564529

Building a protocol expressway: the case of Mayo Clinic Cancer Center.

Terre A McJoynt1, Muhanad A Hirzallah, Daniel V Satele, Jason H Pitzen, Steven R Alberts, S Vincent Rajkumar.   

Abstract

PURPOSE: Inconsistencies and errors resulting from nonstandard processes, together with redundancies, rework, and excess workload, lead to extended time frames for clinical trial protocol development. This results in dissatisfaction among sponsors, investigators, and staff and restricts the availability of novel treatment options for patients.
METHODS: A team of experts from Mayo Clinic formed, including Protocol Development Unit staff and management from the three Mayo Clinic campuses (Florida, Minnesota, and Arizona), a systems and procedures analyst, a quality office analyst, and two physician members to address the identified deficiencies. The current-state process was intensively reviewed, and improvement steps were taken to accelerate the development and approval of cancer-related clinical trials. The primary goal was to decrease the time from receipt of a new protocol through submission to an approving authority, such as the National Cancer Institute or institutional review board.
RESULTS: Using the Define, Measure, Analyze, Improve, Control (DMAIC) framework infused with Lean waste-reduction methodologies, areas were identified for improvement, including enhancing first-time quality and processing new studies on a first-in/first-out basis. The project was successful in improving the mean turnaround time for internally authored protocols (P < .001) from 25.00 weeks (n = 41; range, 3.43 to 94.14 weeks) to 10.15 weeks (n = 14; range, 4.00 to 22.14 weeks). The mean turnaround time for externally authored protocols was improved (P < .001) from 20.61 weeks (n = 85; range, 3.29 to 108.57 weeks) to 7.79 weeks (n = 50; range, 2.00 to 20.86 weeks).
CONCLUSION: DMAIC framework combined with Lean methodologies is an effective tool to structure the definition, planning, analysis, and implementation of significant process changes.

Entities:  

Mesh:

Year:  2009        PMID: 19564529      PMCID: PMC2727289          DOI: 10.1200/JCO.2008.21.4338

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  9 in total

1.  Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.

Authors:  David M Dilts; Alan B Sandler; Matthew Baker; Steven K Cheng; Stephen L George; Kathleen S Karas; Stephen McGuire; Gourija S Menon; Jason Reusch; Debbie Sawyer; Maren Scoggins; Amy Wu; Kai Zhou; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

2.  Estimating the cost of new drug development: is it really 802 million dollars?

Authors:  Christopher P Adams; Van V Brantner
Journal:  Health Aff (Millwood)       Date:  2006 Mar-Apr       Impact factor: 6.301

3.  The Six Sigma initiative at Mount Sinai Medical Center.

Authors:  Robert Chassin
Journal:  Mt Sinai J Med       Date:  2008 Jan-Feb

4.  Application of Six Sigma towards improving surgical outcomes.

Authors:  P J Shukla; S G Barreto; M S Nadkarni
Journal:  Hepatogastroenterology       Date:  2008 Mar-Apr

5.  Leaders worry that U.S. is losing edge on cancer clinical trials.

Authors:  Renee Twombly
Journal:  J Natl Cancer Inst       Date:  2008-08-26       Impact factor: 13.506

Review 6.  The "six sigma approach" to the operating room environment and infection.

Authors:  Robert H Thiele; Julie L Huffmyer; Edward C Nemergut
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-09

7.  Development of clinical trials in a cooperative group setting: the eastern cooperative oncology group.

Authors:  David M Dilts; Alan Sandler; Steven Cheng; Joshua Crites; Lori Ferranti; Amy Wu; Robert Gray; Jean MacDonald; Donna Marinucci; Robert Comis
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

8.  Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.

Authors:  David M Dilts; Alan B Sandler
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

9.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

  9 in total
  7 in total

1.  Evaluating protocol lifecycle time intervals in HIV/AIDS clinical trials.

Authors:  Scott R Rosas; Jeffrey T Schouten; Dennis Dixon; Suresh Varghese; Marie T Cope; Joe Marci; Jonathan M Kagan
Journal:  Clin Trials       Date:  2014-06-30       Impact factor: 2.486

2.  Protocol Development Program: A Novel Approach to Overcoming Barriers to Clinical Research.

Authors:  Tracey J Miller; Vali S Sevastita; Doreen G Chaitt; Jorge A Tavel; Jerome F Pierson
Journal:  Monitor (Assoc Clin Pharmacol)       Date:  2013-02-01

3.  Applying systems engineering to implement an evidence-based intervention at a community health center.

Authors:  Shin-Ping Tu; Sherry Feng; Richard Storch; Mei-Po Yip; HeeYon Sohng; Mingang Fu; Alan Chun
Journal:  J Health Care Poor Underserved       Date:  2012-11

4.  Increasing value and reducing waste in biomedical research regulation and management.

Authors:  Rustam Al-Shahi Salman; Elaine Beller; Jonathan Kagan; Elina Hemminki; Robert S Phillips; Julian Savulescu; Malcolm Macleod; Janet Wisely; Iain Chalmers
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

5.  Use of Lean response to improve pandemic influenza surge in public health laboratories.

Authors:  Judith L Isaac-Renton; Yin Chang; Natalie Prystajecky; Martin Petric; Annie Mak; Brendan Abbott; Benjamin Paris; K C Decker; Lauren Pittenger; Steven Guercio; Jeff Stott; Joseph D Miller
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

6.  Activating clinical trials: a process improvement approach.

Authors:  Diego A Martinez; Athanasios Tsalatsanis; Ali Yalcin; José L Zayas-Castro; Benjamin Djulbegovic
Journal:  Trials       Date:  2016-02-24       Impact factor: 2.279

Review 7.  Does Value Stream Mapping affect the structure, process, and outcome quality in care facilities? A systematic review.

Authors:  Marina Nowak; Holger Pfaff; Ute Karbach
Journal:  Syst Rev       Date:  2017-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.